Statin therapy might be beneficial for patients with ankylosing spondylitis [11]

Annals of the Rheumatic Diseases

Volumn 65, Issue 5, 2006, Pages 695-696

  Van Denderen, J C ^a   Peters, M J L ^b   Van Halm, V P ^b   Van Der Horst Bruinsma, I E ^b   Dijkmans, B A C ^b   Nurmohamed, M T ^a,b  

^a JAN VAN BREEMEN INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ATORVASTATIN; BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA B27 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; ROSUVASTATIN; SALAZOSULFAPYRIDINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; COST BENEFIT ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LETTER; OPPORTUNISTIC INFECTION; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; WILCOXON SIGNED RANKS TEST;

ADULT; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PILOT PROJECTS; PYRIMIDINES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33646239828     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.044503     Document Type: Letter

References (5)

1. Scalapino KJ, Davis JC Jr. The treatment of ankylosing spondylitis. Clin Exp Med 2003;4:159-65.
2. Braun J, Sieper J. Biological therapies in the spondylarthritides - the current state. Rheumatology (Oxford) 2004;43:1072-84.
3. Halcox JPJ, Deanfield JE. Beyond the laboratory: clinical implications for statin pleitropy. Circulation 2004;109(suppl 1):II42-8.
4. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakova O, Ford I, et al. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21.
5. Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.